Position in PFE
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$5,619,790
-$790,733 QoQ
Shares Held
233,380
+2.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#566
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Composition Wealth, LLC holds $115,127,781 across 14 Drug Manufacturers - General names. PFE ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
114,607 | $29,106,739 | |
| 2 | LLY |
ELI LILLY & Co
|
22,959 | $27,537,715 | |
| 3 | ABBV |
AbbVie Inc.
|
67,878 | $17,080,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
99,815 | $12,826,227 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
111,561 | $6,428,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
45,430 | $5,739,626 | |
| 7 | PFE |
Pfizer Inc
This page
|
233,380 | $5,619,790 | |
| 8 | AZN |
Astrazeneca PLC
|
22,766 | $4,316,888 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,619,790 | 233,380 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $6,410,523 | 228,295 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $5,846,594 | 234,803 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,019,879 | 236,259 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $5,707,429 | 235,455 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $5,910,149 | 233,234 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $5,828,641 | 219,700 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $5,718,630 | 197,603 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,484,639 | 196,020 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $5,355,528 | 192,992 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $708,896 | 24,623 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $887,861 | 26,767 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,028,543 | 28,041 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,159,984 | 28,431 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,370,106 | 26,739 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,218,409 | 27,843 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,168,454 | 22,286 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $944,698 | 18,248 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,281,207 | 21,697 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,328,922 | 30,898 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,657,945 | 67,874 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,516,825 | 69,468 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,349,913 | 63,839 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,266,920 | 61,769 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,584,903 | 201,373 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,408,688 | 104,433 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||